PartsTable
Technical Data Sheet
PartsTable / COMPONENT / NDC00467-1202-25
NDC00467-1202-25 ✓ Verified by PartsTable
— · COMPONENT
WHAT YOU NEED TO KNOW
Verify manufacturer and server generation compatibility Check if Option PN or Spare PN — same part, different channel
Confirm exact part number — similar PNs may be different parts
PRODUCT OVERVIEW

LIDOCAINE HYDROCHLORIDE INJECTIO. Key specifications include special_features: PRESERVED, primary_container_type: BOTTLE, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 2.000 MILLILITERS, active_medicament_medicinal_strength: 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT. This product is currently in active production with full OEM support.

This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-068-7667, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00467-1202-25
NSN: 6505-01-068-7667
FSC: 6505
CAGE: 22630 — INVENEX LABORATORIES LIFE TECHNOLOGIES INC (USA)
SPECIFICATIONS
special_featuresPRESERVED
primary_container_typeBOTTLE
pharmaceutical_vehicle_typeAQUEOUS
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
primary_container_content_quantity2.000 MILLILITERS
active_medicament_medicinal_strength2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
NSN6505-01-068-7667
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available LIDOCAINE HYDROCHLORIDE INJECTIO TITLE COMPONENT PN NDC00467-1202-25 MFR LIDOCAINE HYDROCHLORID
KEY FEATURES
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
•
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
•
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
•
PRIMARY CONTAINER TYPE: BOTTLE
TECHNICAL CHARACTERISTICS (FLIS)
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
ACTIVE MEDICAMENT MEDICINAL STRENGTH2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY2.000 MILLILITERS
PHARMACEUTICAL VEHICLE TYPEAQUEOUS
SPECIAL FEATURESPRESERVED
PRIMARY CONTAINER TYPEBOTTLE
VERIFIED SUBSTITUTES & CROSS-REFERENCES 14
LA701627ISSUE4Interchangeable
interchangeable cross-reference
interchangeable
20202Interchangeable
interchangeable cross-reference
interchangeable
91599Interchangeable
interchangeable cross-reference
interchangeable
1004-855Interchangeable
interchangeable cross-reference
interchangeable
5D2-3Interchangeable
interchangeable cross-reference
interchangeable
C53652Interchangeable
interchangeable cross-reference
interchangeable
LIFECYCLE
StatusACTIVE
AvailabilityOEM and secondary market
RoHS CompliantEAR99Not HAZMAT
Ready to buy NDC00467-1202-25?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00467-1202-25?
NDC00467-1202-25 is a LIDOCAINE HYDROCHLORIDE INJECTIO.
What parts can replace NDC00467-1202-25?
There are 14 known substitutes for NDC00467-1202-25: LA701627ISSUE4, 20202, 91599 and 11 more. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00467-1202-25?
NDC00467-1202-25 is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-068-7667. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Comments (0)
No comments yet. Be the first to share what you know.
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00467-1202-25

✓ Validated with multiple authoritative sources, including Government, OEM, and Certified sources.
PartsTable Design LLC · partstable.com
Last verified: July 2026